Sonen Capital’s Abbott ABT Stock Holding History

Sonen Capital’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,500	Closed	-$211K	–	94
2021 Q4	$211K	Buy	+1,500	New	+$192K	0.2%	101

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Sonen Capital's ABT Position: Q1 2022 in Review

Sonen Capital sold out of Abbott (ABT) in Q1 2022, closing a stake of 1,500 shares — an estimated $211K sold.

Sonen Capital first reported a position in ABT in Q4 2021 and held it in 1 quarter. The position peaked at $211K in Q4 2021. 2,761 funds tracked by Wall St. Rank hold ABT as of Q1 2022.

Sonen Capital reported no remaining Abbott position as of Q1 2022 after selling out during the quarter.
Sonen Capital sold 1,500 Abbott shares in Q1 2022, an estimated $211K.
Sonen Capital first reported a position in Abbott in Q4 2021 and held it in 1 quarter.
Sonen Capital's Abbott position peaked at $211K in Q4 2021.
2,761 funds tracked by Wall St. Rank held Abbott as of Q1 2022.

Based on Sonen Capital's 13F filing for Q1 2022, filed 9 May 2022.